Clinical trial
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With…
NCT00103246 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00103246 |
|---|---|
| Title | Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides |
| Official title | Phase I Clinical Trial Using Topical Silicon Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the Treatment of Pre-Malignant and Malignant Skin Conditions |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-melanomatous Skin Cancer, Precancerous Condition |
| Intervention type | Drug |
| Interventions | silicon phthalocyanine 4 |
| Enrollment | 43 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Aug 1, 2010 |
| First posted | Feb 8, 2005 |
| Last update posted | Jan 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: